. Th ese interactions typically occur at the centrosome, with the partner proteins supporting AurA localization and stability, and inducing allosteric changes that contribute to AurA activation. Because of the complex nature of the interactions, the exact mechanism timing the abrupt AurA activation at the mitotic boundary has not been well resolved.
In the past several years, AurA has attracted increasing attention because it has been found to be overexpressed and hyperactivated in a high percentage of tumours arising in breast, colon, ovary and other tissues 10 -14 . Abnormally high AurA activity is oncogenic in various cell line models and is associated with defective cytokinesis and aneuploidy 15 -18 . AurA is now being actively exploited as a target for development of new anti-cancer agents (reviewed in Andrews 19 ) on the basis of this known role as a mitotic regulator. Interestingly, the overexpressed AurA associated with cancer cells has a number of activities that are not specifi c to function in a mitotic compartment. For example, AurA directly phosphorylates and regulates the activity of the RalA GTPase, an EGFR / Ras eff ector important in many cancers 20 , with this activity observed in interphase cells. AurA is not typically mutationally activated in cancer, making the mechanism of its activation in interphase cells somewhat elusive.
Intriguingly, a number of studies have emerged in recent years to challenge the idea that AurA is solely a mitotic kinase even in normal cells. Serum induces AurA activation at the basal body of the cell cilium in non-cycling G0 / G1-phase mammalian cells, causing AurA-dependent ciliary resorption 21 , and hence indirectly impacting the functionality of the cilia-dependent and cancer-relevant Hedgehog signalling cascades 22 . AurA also has been reported to regulate microtubule dynamics in interphase cells 23 , and has been shown to be abundantly expressed in some human adult non-cycling tissues such as kidney 24 . All these studies strongly imply a non-mitotic activity for AurA, and indeed, a distant ortholog of AurA in the green algae Chlamydomonas regulates both resorption and excision of the fl agella (a structure analogous to the mammalian cilium) in response to altered ionic conditions or cues for mating 25 , again suggesting important non-mitotic roles for AurA, although across a great evolutionary distance. However, to date, little eff ort has been made to investigate the non-mitotic activation of AurA in either normal cells or tumours, and mechanistic insight into factors governing such activation is essentially absent.
Our previous work demonstrating that AurA activation occurs before ciliary resorption in interphase cells 21 was based on studies in Chlamydomonas , which implicated an AurA ortholog, CALK, as important for resorption of flagella in that organism 25 . Stimuli that lead to loss of flagella in Chlamydomonas include mating response to pheromone and transient ionic shock 25 . Recent studies in Chlamydomonas have also suggested increasing intraflagellar calcium concentrations during the mating response 26 , shortly before the activation of the CALK kinase. Independently, a study of the Chlamydomonas flagellar excision process emphasized the importance of rapid spatiotemporal patterning of calcium ion distribution as a critical mediating signal 27 . Interestingly, a recent study of oocyte maturation in Xenopus indicated that inhibition of Ca 2 + signalling led to eventual failure to accumulate and activate AurA 28 , although no direct connection was investigated. Cumulatively, these studies led us to hypothesize that AurA might be a direct target of cellular calcium signalling in mammals.
Our work presented here demonstrates that elevated cytoplasmic calcium signals are transmitted rapidly and transiently through calmodulin (CaM) to activate AurA. Th is activation involves direct CaM binding to two sites in the unstructured regions of AurA, and induced by multiple inducers of calcium release from intracellular stores in the endoplasmic reticulum (ER). Th ese results provide the fi rst clear mechanism for AurA activation in non-mitotic cells and potential insight into the timing of activation of AurA at mitosis.
Results

ER release of Ca
2 + rapidly and transiently activates AurA . Rapid and transient Ca 2 + channel activity is stimulated by treatment of kidney cells with the peptide hormone and anti-diuretic arginine vasopressin (AVP) 29, 30 . AVP signals through the AVPR1 receptor to initiate InsP3 and other second-messenger cascades that initiate Ca 2 + release from the ER. Th e AVPR1 receptor is well expressed in the renal cell lines HK-2 and HEK293 ( Fig. 1a ) . To assess whether activation of AurA occurred in this physiological context, we treated the HK-2 proximal tubule-derived human kidney cell line with AVP, and used immunofl uorescence with antibody directed to T 288 (auto-phosphorylated)-AurA to measure AurA activation ( Fig. 1b ) . Strikingly, T
288
-phospho AurA at centrosomes increased threefold within 5 s of AVP treatment, returning to basal levels aft er ~ 2 min ( Fig. 1c ) , whereas total AurA levels were not aff ected ( Fig. 1d ) . AurA activation might be mediated by Ca 2 + infl ux from outside the cell, or by Ca 2 + released from internal ER stores. Using AurAtransfected HEK293 cells, we found an equivalent degree of AurA activation aft er AVP treatment of cells cultured in medium with and without Ca 2 + ( Fig. 1e ) . To confi rm that activation was not specifi c to the AVP-initiating stimulus, we also treated these cells grown in Ca 2 + -free medium with histamine, an InsP3 generating agonist that triggers activation of ER-associated calcium ion channels such as the IP3 receptor 31 . Again T 288 -AurA appeared rapidly aft er stimulation ( Fig. 1f ) .
Th e fact that rapid AurA activation occurred aft er stimulation of cells grown without extracellular Ca 2 + implied that the elevated cytoplasmic Ca 2 + levels resulting from ER release might regulate AurA activation without intrinsic requirement for second messengers transmitting signals from membrane-localized receptors. To further assess this mechanism, we treated AurA-transfected HEK293 cells with the Ca 2 + uptake inhibitor thapsigargin, which blocks the recycling of cytoplasmic Ca 2 + into ER stores 32 , thus increasing cytoplasmic Ca 2 + levels without the involvement of upstream activators. Th apsigargin treatment caused a rapid ( < 1 min) increase in levels of activated T 288 -AurA, and increased the in vitro kinase activity of immunoprecipitated AurA against defi ned substrates ( Fig. 2a,b ) .
As another test, the BAPTA-AM Ca 2 + ion chelator blocks Ca 2 + -mediated signalling pathway activation 33 ; BAPTA-AM used alone or at low concentration in combination with EGTA completely blocked thapsigargin-induced T 288 -AurA auto-phosphorylation ( Fig. 2c ) . In the absence of BAPTA-AM, EGTA (which chelates only extracellular Ca 2 + ) had no eff ect either used alone or in conjunction with thapsigargin ( Fig. 2d ) . In addition, treatment with the Ca 2 + -selective ionophore, ionomycin, which directly triggers Ca 2 + release, similarly induced transient activation of AurA with similar kinetics ( Fig. 2e ) . Further, a small molecule inhibitor of AurA, PHA680632 34 , blocked thapsigargin-or ionomycin-induced AurA auto-phosphorylation ( Fig. 2f ) .
Th e AurA partner protein, NEDD9, has been shown to be important for AurA activation in mitosis and in ciliary resorption 9, 21 , and been shown to be rapidly tyrosine phosphorylated (associated with more effi cient function as an activator for some NEDD9 partner proteins) aft er Ca 2 + release in osteoclasts 35, 36 .
However, in cells transfected with small interfering RNA-depleting NEDD9, thapsigargin induced comparable AurA phosphorylation to that in control transfected cells ( Fig. 2g ) . Th ese data indicated that calcium-activated AurA phosphorylation is independent from NEDD9 activity, causing us to investigate other activation mechanisms. In an in vitro kinase assay, titration of Ca 2 + into the reaction did not aff ect AurA auto-phosphorylation or activity towards substrates such as histone H3 ( Fig. 3a ) . However, addition of Ca 2 + with CaM strongly induced AurA auto-phosphorylation, as well as AurA phosphorylation of multiple canonical substrates including histone H3, MBP and NEDD9
( Fig. 3a -c ). In addition, the AurA inhibitor PHA680632 also blocked CaM-induced phosphorylation ( Fig. 3c ) .
Th ese results predicted direct AurA-CaM binding. Th is binding was confi rmed both in vitro and in vivo ( Fig. 3d, e ) , and was positively regulated by Ca 2 + ( Fig. 3e ). Treatment with PHA680632 had no eff ect on AurA-CaM binding ( Fig. 3f ) , as would be expected based on defi ned PHA680632 interactions with a unique site in the hinge region of the AurA catalytic domain 37 . CaM pulldown was specifi c to AurA, as a much weaker pulldown was seen with the related Ipl kinase AurB and no pulldown was seen with an unrelated kinase, Src ( Fig. 3g ) . Further, thapsigargin-induced activation of endogenous AurA in HK-2 cells and of transfected AurA in HEK293 cells was completely blocked by the CaM inhibitor calmidazolium ( Fig. 3h, i ) . Using mass spectrometry, we determined that addition of CaM to AurA resulted in the appearance of a substantial S 51 or S 53 -phosphorylated AurA species (QRVLCP-S(51)-NSSQR), as well as additional phosphorylation events on S 66 or S 67 , and S 98 . Interestingly, phosphorylation of S 53 of the Xenopus AurA ortholog (analogous to S 51 in human AurA) has been previously shown to be a product of mitotic auto-phosphorylation, and to stabilize AurA from proteasomal degradation at mitotic exit 38, 39 .
Defi nition of CaM-binding sites on AurA . CaM binding is typically modulated by a combination of defi ned amino acid motifs and a disordered secondary structure with the potential to form an α -helix 40 . We used four programs for predicting intrinsically disordered regions in proteins (IUPRED, MetaPRDOS, PONDR_FIT and VL3) to analyse AurA structure ( Fig. 4a ) . Th is analysis showed that consensus regions encompassed within approximately residues 1 -127 and 385 -403 were predicted to be disordered. A crystal structure of residues 100 -403 of AurA has been determined 37 (Protein Data Bank entry 2J4Z), and only residues 126 -389 are seen in the , and then T 288 -phAurA levels were analysed by enzyme-linked immunosorbent assay (ELISA), based on A 450 nm . To confi rm the specifi city of ELISA signal, a parallel group of HK2 cells were pre-treated with the AurA inhibitor PHA680632 (PHA) at 500 nM concentration. * P < 0.05 . Lysis buffer was used as a negative control. ( g ) AurA-overexpressing HEK293 cells were transfected with siRNAdepleting NEDD9 (siNEDD9) or scrambled control siRNA (scr), and then were incubated with 5-μ m thapsigargin and processed as in a . For this and subsequent SDS -PAGE analyses, each experiment was performed three times independently, with error bars indicating the standard error. * P < 0.05. density map, confi rming the disorder prediction. Th ese residues also coincide with the canonical N-and C-terminal kinase domains, for example, as defi ned by the PFAM database 41 . In addition, we used the secondary structure prediction program PSIPRED 42,43 on a set of AurA orthologs from mammals and Xenopus ( Fig. 4b ) , identifying two regions of helical propensity in the N-terminal disordered region, consisting of residues 59 -82 and 111 -127 in the human sequence. Th e C-terminal disordered region is predicted to be coiled, and not an α -helix or β -sheet. However, just before this region, residues 353 -364 and 367 -387 are α -helices in the experimental structure.
Further refi nement of this analysis allowed the mapping of a strong minimal interaction domain to residues 33 -89, and suggested weaker binding elements encompassed within residues 82 -132, 350 -368 and 368 -403 ( Fig. 4c,d ) . Suggestively, the minimum strong CaM-AurA-binding site encompassed the longest of the predicted α -helices in the N-terminal disordered region (residues 59 -82), with the α -helices adjacent to or containing the Ca 2 + -dependent auto-phosphorylation sites (S ). Further, the α -helix, the phosphorylation sites and the fl anking sequences show striking conservation through mammals ( Fig. 4b ) , implying an important function. Th e weaker binding of CaM to the other minimal binding elements may be due to unfolding of the protein in some constructs; for example, the predicted helical regions in residues 350 -368 are encompassed in the catalytic domain, and would normally be folded. However, we cannot rule out local unfolding of this region and CaM binding in intact AurA, based on interactions of AurA with partner proteins.
Discussion
Th e work presented here reveals and mechanistically defi nes a novel role for AurA as a component of rapid calcium signalling responses. In interphase cells, we propose that transient stimuli such as AVP or histamine trigger Ca 2 + release into the cytoplasm, inducing CaM binding and auto-activation of AurA. Th ese activities involve diff erent activation mechanisms than those we have previously reported for AurA in regulation of ciliary disassembly 21 , occurring with much faster kinetics (2-5 min versus 1 -2 h) and not infl uenced by depletion of NEDD9. Although our data do not exclude the possibility that second messengers or cilia-based signalling systems may contribute to the activation of AurA in calcium response, they argue against an essential requirement for such activation. Such transient activation of AurA in response to short-term increases in cytoplasmic calcium may off er a mechanism by which AurA is able to phosphorylate targets such as RalA 20 and microtubules 23 in non-mitotic cells. Interestingly, RalA is itself regulated by Ca 2 + in a non-Ras-dependent activation pathway 44 , and RalA activity has been reported to be controlled by CaM binding 45 . Our data raise the possibility that parallel CaM-dependent activation of AurA may help control the degree and timing of RalA activation in cancer and normal cells. Th e activation of AurA by Ca 2 + -CaM may also have implications for AurA functions at cilia. Th e polycystic kidney disease (PKD)-associated genes PKD1 and PKD2 encode cilia-associated, heterodimerizing proteins that function as mechanosensors, internalizing Ca 2 + in response to fl ow-based cues 46 . Th is localized release of Ca 2 + may transiently activate AurA, given the proximal location of the AurA protein at the ciliary basal body, allowing AurA to phosphorylate substrates relevant to the mechanosensing process. For example, AurA exists in a stable complex with NEDD9, and NEDD9 (HEF1) has previously been reported to bind the Id2 47 , a protein that is phosphorylated and infl uences cell diff erentiation in response to PKD1 / PKD2-mediated signalling 48 . Th ese data also off er insight into control mechanisms operant in the cell cycle-regulated activation of AurA. Dynamic changes in calcium signalling have a key role in meiosis, have been implicated in action at spindle-associated microdomains in mitosis 49 and may also regulate AurA. An attractive feature of Ca 2 + -dependent AurA regulation is that it off ers a potential mechanism to help explain the rapid, timed activation of AurA at cell cycle transitions. At present, although multiple proteins have been demonstrated to bind and support AurA activation at the mitotic boundary, most of these also interact with AurA in G2, implying the existence of a triggering event at the actual transition point. Th e transient increase of cytoplasmic Ca 2 + could provide a suitable mitotic trigger. Such Ca 2 + -and CaM-dependent regulation of the centrosomal proteins centrin and CP110 has been shown to be critical for the action of these proteins in supporting cytokinesis. In this view, Ca 2 + release and CaM binding may be a physiological trigger for AurA during cell cycle, causing conformational changes that are permissive for other AurAinteracting proteins to sustain its activity during long-term rather than transient responses. Intriguingly, calcium signalling diff ers signifi cantly in cancerous 50 versus normal cells, promoting increased cell proliferation through the abnormal activation of numerous calcium-responsive signalling pathways. Hence, our work also raises the possibility that the enhanced AurA activity oft en found in tumours may, in part, arise from an abnormal calcium signalling environment. Th ese points merit further investigation.
Methods
Plasmids and cell culture . FLAG-and glutathione S-transferase (GST)-fused HEF1 were expressed from the vectors pCatch-FLAG 51 and pGEX-2T 52 , respectively, as previously described. AurA and derivatives were expressed from pCMV-SPORT6-C6 ( OpenBiosystems ) and pcDNA3.1-mRFP vectors. A PCR product of mRFP was ligated into pcDNA3.1( + ) ( Invitrogen ) to create pcDNA3.1-mRFP. pcDNA3.1-mRFP was used as a negative control. Catalytically inactive AurA (K162R) was prepared using a site-directed mutagenesis kit ( Stratagene ). HEK293 cells were maintained in Dulbecco ' s modifi ed Eagle ' s medium with 10 % fetal bovine serum plus penicillin / streptomycin. Th e immortalized human kidney proximal tubular cell line ( HK-2 , ATCC , cat. no. CRL-219) was grown to subconuence in keratinocyte media ( Invitrogen ). We transiently transfected HEK293 cells with expression constructs for HEF1 and AurA using Lipofectamine and Plus reagent ( Invitrogen ) according to the manufacturer ' s instructions.
Immunofl uorescence . Cells growing on coverslips were fi xed with 4 % paraformaldehyde (10 min) and cold methanol (5 min), permeabilized with 1 % Triton X-100 in phosphate-buff ered saline (PBS), blocked in 1 × PBS with 3 % bovine serum albumin and incubated with antibodies using standard protocols. Primary antibodies included mouse anti-AurA ( BD Biosciences ; 1:200) and rabbit polyclonal antiphospho-AurA / T288 ( Cell Signaling ; 1:100). Secondary antibodies labelled with Alexa-488, Alexa-568 and DAPI (4 ' ,6-diamidino-2-phenylindole) to stain DNA, were from Mole cular Probes / Invitrogen (1:2000). Confocal microscopy was performed using a Nikon C1 spectral confocal microscope ( Nikon ).
Western blotting and immunoprecipitation . Recombinant Hexa-histidine AurA was produced in a baculovirus expression system. For western blotting and immunoprecipitation, mammalian cells were disrupted in CelLytic M lysis buff er ( Sigma ) supplemented with a protease and phosphates inhibitor cocktails ( Roche ). Wholecell lysates were used either directly for SDS polyacrylamide gel electrophoresis (SDS -PAGE) or for immunoprecipitation. Immuno precipitation samples were incubated overnight with antibody at 4 ° C, and subsequently incubated for 2 h with protein A / G-sepharose ( Pierce ), washed and resolved by SDS -PAGE.
Western blotting was done using standard procedures, and developed by chemiluminescence using the West-Pico system ( Pierce ). Primary antibodies included mouse anti-NEDD9 mAb (clone 2G9 9 ; 1:1000), anti-AurA ( BD Biosciences ; 1:3000), anti-phospho-AurA-T 288 and anti-GST mAb ( Cell Signaling ; 1:2000), anti-V1aR ( Santa Cruz Biotechnology ; 1:600) and anti-β -actin mAb (AC15, Sigma ;1:20,000). Polyclonal anti-AurA agarose-immobilized conjugate ( Bethyl ) were used for immunoprecipitations. Secondary anti-mouse and antirabbit horseradish peroxidase-conjugated antibodies ( GE Healthcare ) were used at a dilution of 1:10,000 for visualization of western blots. Image analysis was done using NIH ImageJ -Image Processing and Analysis soft ware ( National Institutes of Health ), with signal intensity normalized to β -actin or total AurA level.
Structural analysis . Four programs that predict intrinsically disordered regions were used via their webservers: IUPRED 53 , MetaPRDOS 54 , PONDR_FIT 55 and VL3 56 . PSI-BLAST 57 was used to search the Uniprot database 58 to fi nd orthologs of AurA and to identify crystal structures of AurA in the Protein Data Bank. A selection of these sequences was retrieved and a multiple sequence alignment was performed with Clustal W 59 . Th e program PSIPRED 43 was used to predict secondary structure for these sequences based on single sequence predictions, rather than multiple sequence alignments from PSI-BLAST.
CaM association studies . Cell lysates in lysis buff er (PBS with 1 % Triton X-100) or purifi ed GST fusion protein diluted in binding buff er (50 mM Tris -HCl (pH 7.6), 120 mM NaCl, 1 % Brij) were incubated with CaM-Sepharose 4B ( GE Healthcare ) or control Sepharose for 1 -2 h at 4 ° C, as indicated in the fi gure legends. In defi ned in vitro experiments, AurA was purifi ed from baculovirus, as previously described 21 , whereas recombinant proteins AurB or Src were obtained from Millipore . Aft er washing, beads were boiled in SDS sample buff er and separated by SDS -PAGE followed by western blotting.
Phosphorylation assays . MBP, histone H3 ( Upstate ) and histone H1 ( Upstate ) were used as positive and negative controls for AurA phosphorylation using standard methods. Parallel aliquots without γ -32 P(ATP) were processed for SDS -PAGE / Coomassie staining ( Invitrogen ). To assess CaM-dependent AurA activation, in vitro kinase assay was performed using AurA purifi ed from baculovirus or according the protocol described above, in the presence of 1 μ M CaM ( Calbiochem ) and 1 mM Ca 2 + . For kinase assay without Ca 2 + , 1 mM EGTA was substituted for 1 mM Ca 2 + in the kinase buff er. Endogenous phospho-T 288 -AurA protein in HK2 cells was detected by PathScan Phospho-AurA Sandwich ELISA kit ( Cell Signaling ) according to the manufacturer ' s instructions.
Mass spectrometry . Aft er an in vitro kinase reaction with AurA produced from baculovirus in the presence or absence of CaM plus 1 mM CaCl 2 , gels were stained with Coomassie blue and phospho rylated AurA bands were excised and sequenced at the Taplin Biological Mass Spectrometry Facility at Harvard Medical School, by using microcapillary reverse-phase HPLC nanoelectrospray tandem mass spectrometry on a Finnigan LCQ DECA quadrupole ion trap mass spectrometer.
Statistical analysis . Statistical comparisons were made using a two-tailed Student ' s t -test. Experimental values were reported as the means ± s.e. Diff erences in mean values were considered signifi cant at P < 0.05. All calculations of statistical significance were made using the GraphPad InStat soft ware package ( GraphPad ).
